🔎 Trials Near Me

Akèy › Kasinòm epitelyal ovè › Kalifòni

Etid klinik pou Kasinòm epitelyal ovè nan Kalifòni

10 etid pou Kasinòm epitelyal ovè ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
  • Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
  • California Pacific Medical Center - Van Ness Campus /ID# 275329, San Francisco
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT06890338

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of California, San Diego, La Jolla
  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Redwood City, Redwood City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

  • Research Site, La Jolla
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Jul 21, 2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Disney Family Cancer Center, Burbank
  • Scripps Clinic, La Jolla
  • Palo Alto Medical Foundation, Palo Alto
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Jul 2, 2026 · NCT06819007

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • Beckman Research Institute of City of Hope, Duarte
  • VA Medical Center, Fresno, Fresno
  • Santa Clara Valley Medical Center, Fruitdale
  • ak 5 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

  • City of Hope National Medical Center, Duarte
  • Providence St. Jude Medical Center, Fullerton
  • UCLA - JCCC Clinical Research Unit, Los Angeles
  • ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Dec 23, 2025 · NCT06690775

A Study of NX-1607 in Adults With Advanced Malignancies

  • University of Southern California, Los Angeles
  • University of California, San Francisco, San Francisco
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Moores Cancer Center UC San Diego Health, La Jolla
  • Keck School of Medicine of USC, Los Angeles
  • UCLA, Los Angeles
  • ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 15, 2025 · NCT04429542

A Beta-only IL-2 ImmunoTherapY Study

  • Sharp Memorial Hospital, San Diego
  • Providence Saint John's Health Center, Santa Monica
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2025 · NCT05086692

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

  • UC San Diego Moores Cancer Center, La Jolla
  • Stanford University, Stanford
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 8, 2024 · NCT04282044

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.